MedTrace Logo

A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese Population

NCT06394076 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2024-05-01

No results posted yet for this study

Summary

A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of MAILI PRECISE With Lidocaine Injectable Gel for Correction of Infraorbital Hollowing in Chinese Population

Conditions

  • Infraorbital Hollowing

Interventions

DEVICE

Cross-linked sodium hyaluronate gel for injection containing lidocaine

Cross-linked sodium hyaluronate gel for injection containing lidocaine

Sponsors & Collaborators

  • Sinclair Pharmaceuticals Limited

    lead INDUSTRY

Principal Investigators

  • Hongsen Bi · Peking University Third Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-27
Primary Completion
2024-04-30
Completion
2025-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06394076 on ClinicalTrials.gov